Online citations, reference lists, and bibliographies.
← Back to Search

Transient And 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment Of Alcoholic Liver Fibrosis And Cirrhosis.

M. Thiele, S. Detlefsen, Linda Sevelsted Møller, Bjørn Stæhr Madsen, Janne Fuglsang Hansen, Annette Dam Fialla, J. Trebicka, A. Krag
Published 2016 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
BACKGROUND & AIMS Alcohol abuse causes half of all deaths from cirrhosis in the West, but few tools are available for noninvasive diagnosis of alcoholic liver disease. We evaluated 2 elastography techniques for diagnosis of alcoholic fibrosis and cirrhosis; liver biopsy with Ishak score and collagen-proportionate area were used as reference. METHODS We performed a prospective study of 199 consecutive patients with ongoing or prior alcohol abuse, but without known liver disease. One group of patients had a high pretest probability of cirrhosis because they were identified at hospital liver clinics (in Southern Denmark). The second, lower-risk group, was recruited from municipal alcohol rehabilitation centers and the Danish national public health portal. All subjects underwent same-day transient elastography (FibroScan), 2-dimensional shear wave elastography (Supersonic Aixplorer), and liver biopsy after an overnight fast. RESULTS Transient elastography and 2-dimensional shear wave elastography identified subjects in each group with significant fibrosis (Ishak score ≥3) and cirrhosis (Ishak score ≥5) with high accuracy (area under the curve ≥0.92). There was no difference in diagnostic accuracy between techniques. The cutoff values for optimal identification of significant fibrosis by transient elastography and 2-dimensional shear wave elastography were 9.6 kPa and 10.2 kPa, and for cirrhosis 19.7 kPa and 16.4 kPa. Negative predictive values were high for both groups, but the positive predictive value for cirrhosis was >66% in the high-risk group vs approximately 50% in the low-risk group. Evidence of alcohol-induced damage to cholangiocytes, but not ongoing alcohol abuse, affected liver stiffness. The collagen-proportionate area correlated with Ishak grades and accurately identified individuals with significant fibrosis and cirrhosis. CONCLUSIONS In a prospective study of individuals at risk for liver fibrosis due to alcohol consumption, we found elastography to be an excellent tool for diagnosing liver fibrosis and for excluding (ruling out rather than ruling in) cirrhosis.
This paper references
10.11152/MU.2013.2066.154.ISP2
How many measurements are needed for liver stiffness assessment by 2D-Shear Wave Elastography (2D-SWE) and which value should be used: the mean or median?
I. Sporea (2013)
10.1111/j.1530-0277.2012.01737.x
Rapid decline of liver stiffness following alcohol withdrawal in heavy drinkers.
Jean-Baptiste Trabut (2012)
10.1016/j.jhep.2015.04.006
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.
Asociacion Latinoamericana para el Estudio del Higado (2015)
10.1016/j.jhep.2015.05.022
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.
R. de Franchis (2015)
10.1038/ajg.2015.191
Causes of Death in People with Liver Cirrhosis in England Compared with the General Population: A Population-Based Cohort Study
S. Ratib (2015)
10.1016/j.cgh.2014.07.037
Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases.
F. Nascimbeni (2015)
10.1080/10826080802347586
Comparison of the Quick Drinking Screen and the Alcohol Timeline Followback with Outpatient Alcohol Abusers
M. Roy (2008)
10.3748/WJG.V16.I8.966
Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis.
S. Mueller (2010)
Liver biopsy. Hepatology 2009;49:1017-1044
DC Rockey (2009)
10.1053/J.GASTRO.2004.11.018
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.
L. Castéra (2005)
10.1002/HEP.1840110302
Agreement among multiple observers on endoscopic diagnosis of esophageal varices before bleeding
F. Bendtsen (1990)
10.1016/j.jhep.2012.12.021
Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard.
T. Poynard (2013)
10.1016/j.jhep.2014.10.042
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards.
J. Boursier (2015)
10.1016/j.jhep.2008.08.011
Assessment of liver fibrosis using transient elastography in patients with alcoholic liver disease.
P. Nahon (2008)
10.1002/hep.22745
Computer‐assisted image analysis of liver collagen: Relationship to Ishak scoring and hepatic venous pressure gradient
V. Calvaruso (2009)
10.1016/j.cgh.2014.12.014
Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study.
N. Afdhal (2015)
10.1016/j.jhep.2013.12.023
Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis.
E. Tsochatzis (2014)
10.1016/j.jhep.2014.09.020
Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography.
T. Deffieux (2015)
10.1016/S0895-4356(03)00254-3
The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis.
B. Aertgeerts (2004)
10.1053/j.gastro.2010.06.015
Reduced mortality rates following elective percutaneous liver biopsies.
J. West (2010)
10.3748/wjg.v19.i4.516
Effect of alcohol consumption on liver stiffness measured by transient elastography.
E. Bardou-Jacquet (2013)
10.1016/S0140-6736(84)90295-2
PROSPECTIVE EVALUATION OF ALCOHOL ABUSE AND ALCOHOLIC LIVER INJURY IN MEN AS PREDICTORS OF DEVELOPMENT OF CIRRHOSIS
ThorkildI. A. Sørensen (1984)
10.1002/hep.21665
Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis
F. Vizzutti (2007)
10.1056/NEJM197810262991705
Problems of spectrum and bias in evaluating the efficacy of diagnostic tests.
D. Ransohoff (1978)
10.1016/j.jhep.2014.04.045
Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
F. Macaluso (2014)
10.1002/hep.25993
Determination of reliability criteria for liver stiffness evaluation by transient elastography
J. Boursier (2013)
10.1002/hep.23686
Alcoholic liver disease: The buzz may be gone, but the hangover remains
V. Shah (2010)
10.1053/JHEP.2002.36128
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
X. Forns (2002)
10.1093/OXFORDJOURNALS.ALCALC.A008408
Meta-analysis of alcohol intake in relation to risk of liver cirrhosis.
G. Corrao (1998)
10.1016/j.jhep.2013.03.007
Global burden of alcoholic liver diseases.
J. Rehm (2013)
10.1016/J.ULTRASMEDBIO.2017.08.1487
Transient Elastography for Diagnosis of Stages of Hepatic Fibrosis and Cirrhosis in People with Alcoholic Liver Disease
C. Pavlov (2017)
10.1002/hep.25936
Accuracy of real‐time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: A pilot study
G. Ferraioli (2012)
10.1111/j.1365-2036.2008.03831.x
Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non‐invasive laboratory tests
E. Nguyen-Khac (2008)
10.1016/J.JHEP.2015.05.022
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
R. Franchis (2015)
10.1016/j.jhep.2014.12.007
Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension.
B. Procopeţ (2015)
10.3399/bjgp13X673711
Feasibility of detection and intervention for alcohol-related liver disease in the community: the Alcohol and Liver Disease Detection study (ALDDeS).
N. Sheron (2013)
10.1046/j.1365-2893.1997.00141.x
Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus
T. Poynard (1997)
10.1148/radiol.13130128
Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation.
Vivian Yee-fong Leung (2013)
10.1016/j.jhep.2014.04.044
Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.
C. Cassinotto (2014)
10.3109/00365521.2012.661759
Incidence, etiology and mortality of cirrhosis: a population-based cohort study
A. D. Fialla (2012)
10.1016/j.jhep.2014.02.031
Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome.
Y. Huang (2014)



This paper is referenced by
10.1016/j.ultrasmedbio.2020.03.025
Liver Elastography in Primary Sclerosing Cholangitis Patients Using Three Different Scanner Systems.
Anders Batman Mjelle (2020)
10.1016/j.gastre.2019.09.003
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH.
Ramón Bataller (2019)
10.1016/j.jhep.2018.03.018
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.
M. Thursz (2018)
10.1111/apt.13587
Editorial: in vino veritas – transient elastography for staging liver fibrosis in alcoholic liver disease – authors' reply
C. Pavlov (2016)
Effect of load on shear wave speed in muscle
Xiao Chen (2017)
10.1007/s40477-017-0260-7
Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness
L. Mulazzani (2017)
10.1016/j.gastrohep.2017.12.003
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.
R. Aller (2018)
10.1155/2016/7629724
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
Ruchi Bansal (2016)
10.1007/978-3-319-98890-0
The Human Gut-Liver-Axis in Health and Disease
Aleksander Krag (2019)
10.1177/0004563219879962
A review of the clinical utility of the Enhanced Liver Fibrosis test in multiple aetiologies of chronic liver disease
Preya J Patel (2019)
10.1155/2019/3527809
Protocatechuic Acid-Mediated miR-219a-5p Activation Inhibits the p66shc Oxidant Pathway to Alleviate Alcoholic Liver Injury
Rong Fu (2019)
10.1016/j.cld.2018.09.005
Acute Alcoholic Hepatitis.
Gene Y Im (2019)
10.1016/S2468-1253(19)30415-7
Outpatient management of alcohol-related liver disease.
D. Simonetto (2020)
10.3390/life10090198
Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
Ma Ai Thanda Han (2020)
10.1016/j.cgh.2019.01.026
Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.
N. Shah (2019)
10.1148/radiol.2018170601
Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.
P. Kennedy (2018)
10.1097/MPG.0000000000002320
Normal Liver Stiffness Values in Children: A Comparison of Three Different Elastography Methods
Anders Batman Mjelle (2019)
10.1055/s-0043-103955
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version).
C. F. Dietrich (2017)
10.1053/j.gastro.2018.01.005
Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.
M. Thiele (2018)
10.5772/intechopen.89970
Noninvasive Assessment of Diffuse Liver Diseases Using Vibration-Controlled Transient Elastography (VCTE)
Monica Lupsor-Platon (2019)
Molecular MRI of activated hepatic stellate cells in rats with early stage of liver fibrosis by targeting hepatic integrin α 5 β 1
W. Zhang (2016)
Non-alcoholic fatty liver disease (NAFLD) : perspectives to etiology, complications and lipid metabolism
Aki Juhani Käräjämäki (2017)
10.1016/j.jhepr.2020.100067
Limitations of non-invasive tests for assessment of liver fibrosis
Keyur Patel (2020)
10.1002/hep.30979
Cost‐Effectiveness of Noninvasive Screening for Alcohol‐Related Liver Fibrosis
L. Asphaug (2019)
10.1016/j.ultrasmedbio.2018.07.008
Liver Ultrasound Elastography: An Update to the World Federation for Ultrasound in Medicine and Biology Guidelines and Recommendations.
G. Ferraioli (2018)
10.1016/j.jhep.2019.08.019
Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia.
M. Serra-Burriel (2019)
10.1111/liv.14383
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol‐associated liver disease
G. Addolorato (2020)
10.11152/MU-2063
General advice in ultrasound based elastography of pediatric patients.
C. Dietrich (2019)
Morphologic features of alcohol-related liver disease: Correlation with clinical stages and prognostic relevance
Patrick Käferböck (2019)
Clinical Practice Guidelines : Management of alcohol-related liver disease q European Association for the Study of the Liver
C. Lackner (2018)
10.14366/usg.19013
Assessment of liver fibrosis using 2-dimensional shear wave elastography: a prospective study of intra- and inter-observer repeatability and comparison with point shear wave elastography
J. Yoo (2019)
10.1111/apt.14529
Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
T. Karlas (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar